H Vergin

687 total citations
56 papers, 544 citations indexed

About

H Vergin is a scholar working on Pharmacology, Surgery and Oncology. According to data from OpenAlex, H Vergin has authored 56 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 12 papers in Surgery and 9 papers in Oncology. Recurrent topics in H Vergin's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Nausea and vomiting management (7 papers). H Vergin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Nausea and vomiting management (7 papers). H Vergin collaborates with scholars based in Switzerland, Germany and Austria. H Vergin's co-authors include Hermann Mascher, P. Muth, W. Bolten, Richard Metz, Istvan Szelenyi, G Hitzenberger, Christian Kikuta, Annamaria Painold, Martin D. Brand and Christian Meisel and has published in prestigious journals such as Journal of Chromatography A, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

H Vergin

54 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Vergin Switzerland	11	177	95	81	79	74	56	544
André J. Jackson United States	19	165 0.9×	79 0.8×	93 1.1×	59 0.7×	36 0.5×	46	800
Edward J. Mroszczak United States	13	360 2.0×	67 0.7×	118 1.5×	54 0.7×	138 1.9×	26	794
Parviz Mojaverian United States	18	117 0.7×	103 1.1×	132 1.6×	23 0.3×	129 1.7×	41	886
Arzu Selen United States	18	253 1.4×	77 0.8×	139 1.7×	99 1.3×	32 0.4×	30	931
Bernard E. Cabana United States	16	175 1.0×	86 0.9×	200 2.5×	57 0.7×	26 0.4×	42	872
Dale A. Raines Saudi Arabia	13	102 0.6×	87 0.9×	50 0.6×	53 0.7×	43 0.6×	25	448
Loretta Franceschi Italy	11	194 1.1×	50 0.5×	62 0.8×	88 1.1×	40 0.5×	19	509
Kohji Naora Japan	13	194 1.1×	45 0.5×	142 1.8×	83 1.1×	61 0.8×	56	553
Adnan El‐Yazigi Saudi Arabia	15	110 0.6×	72 0.8×	94 1.2×	36 0.5×	26 0.4×	60	597
Joan Moncrieff South Africa	13	137 0.8×	78 0.8×	78 1.0×	34 0.4×	30 0.4×	39	467

Countries citing papers authored by H Vergin

Since Specialization

Citations

This map shows the geographic impact of H Vergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Vergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Vergin more than expected).

Fields of papers citing papers by H Vergin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Vergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Vergin. The network helps show where H Vergin may publish in the future.

Co-authorship network of co-authors of H Vergin

This figure shows the co-authorship network connecting the top 25 collaborators of H Vergin. A scholar is included among the top collaborators of H Vergin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Vergin. H Vergin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Letmaier, Martin, Annamaria Painold, Anna K. Holl, R. Grohmann, & H Vergin. (2012). Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. International Journal of Psychiatry in Clinical Practice. 16(2). 153–156. 6 indexed citations

Letmaier, Martin, Annamaria Painold, Anna K. Holl, et al.. (2011). Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. The International Journal of Neuropsychopharmacology. 15(6). 739–748. 57 indexed citations

Wigand, R., et al.. (2004). Celecoxib in der symptomatischen Therapie bei aktivierter Osteoarthrose oder rheumatoider Arthritis. DMW - Deutsche Medizinische Wochenschrift. 129(21). 1188–1192. 4 indexed citations

Brand, Martin D., Stefan Krauß, Christian Meisel, et al.. (2003). Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells. Arthritis & Rheumatism. 48(5). 1438–1444. 60 indexed citations

Muth, P., et al.. (1998). Sensitive high-performance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma. Journal of Chromatography A. 810(1-2). 63–69. 13 indexed citations

Muth, P., et al.. (1996). Improved high-performance liquid chromatographic determination of amoxicillin in human plasma by means of column switching. Journal of Chromatography A. 729(1-2). 259–266. 33 indexed citations

Muth, P., et al.. (1996). Improved determination of sulfadiazine in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. 729(1-2). 243–249. 10 indexed citations

Muth, P., et al.. (1996). Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. 729(1-2). 251–258. 36 indexed citations

Vergin, H, et al.. (1995). Pharmacokinetics and bioavailability of different formulations of aciclovir.. PubMed. 45(4). 508–15. 35 indexed citations

10.

Mascher, Hermann, et al.. (1992). New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection. Journal of Chromatography B Biomedical Sciences and Applications. 583(1). 122–127. 39 indexed citations

11.

Vergin, H, et al.. (1990). Putative mechanisms of cytoprotective effect of certain antacids and sucralfate. Digestive Diseases and Sciences. 35(11). 1320–1327. 9 indexed citations

12.

Vergin, H, et al.. (1990). Bioavailability and pharmacokinetics of rectally administered metoclopramide.. PubMed. 40(6). 679–83. 6 indexed citations

13.

Vergin, H, et al.. (1989). Oral Bioavailability of Atenolol. Journal of International Medical Research. 17(5). 417–425. 6 indexed citations

14.

Vergin, H, et al.. (1987). Gastric Prostaglandin E₂Release Induced by Aluminium Hydroxide and Aluminium Hydroxide-Containing Antacids in Rats: Effect of Low Doses and Citric Acid. Scandinavian Journal of Gastroenterology. 22(7). 884–888. 8 indexed citations

15.

Vergin, H, et al.. (1986). Pharmacokinetics and bioequivalence of different formulations of pirenzepine.. PubMed. 36(9). 1409–12. 5 indexed citations

16.

Vergin, H, et al.. (1983). [Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].. PubMed. 33(3). 458–62. 2 indexed citations

17.

Szelenyi, Istvan, H Engler, Peter Herzog, et al.. (1982). Influence of nonsteroidal anti-inflammatory compounds on healing of chronic gastric ulcers in rats. Inflammation Research. 12(1-2). 180–182. 17 indexed citations

18.

Vergin, H, et al.. (1981). Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients. Infection. 9(5). 239–243. 6 indexed citations

19.

Vergin, H, et al.. (1981). Pharmacokinetics and biotransformation of benzbromarone in man. European Journal of Clinical Pharmacology. 19(6). 431–435. 25 indexed citations

20.

Vergin, H, et al.. (1980). [Synthesis of radioactively labelled tetroxoprim (author's transl)].. PubMed. 30(2). 307–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact